Akinyemi I. Ojesina, MD, PhD

Publications

• Treatment-related Correlates of Growth in Children With Sickle Cell Disease in the DISPLACE Cohort.

  (Galadanci NA, Sohail M, Akinyelure OP, Kanter J, Ojesina AI.) J Pediatr Hematol Oncol. 2022 Jul 01;44(5):249-254 PMID: 34486556 PMCID: PMC8898314 09/07/2021

• Genome-wide variants and polygenic risk scores for cognitive impairment following blood or marrow transplantation.

  (Sharafeldin N, Zhang J, Singh P, Bosworth A, Chen Y, Patel SK, Wang X, Francisco L, Forman SJ, Wong FL, Ojesina AI, Bhatia S.) Bone Marrow Transplant. 2022 Jun;57(6):925-933 PMID: 35379913 PMCID: PMC9233077 04/06/2022

• Partnership status and retention in care among cisgender heterosexual newly diagnosed people with HIV: a cohort study.

  (Sohail M, Long DM, Mugavero MJ, Batey DS, Ojesina AI, Levitan EB.) AIDS Care. 2022 Mar 29:1-9 PMID: 35348413 PMCID: PMC9519801 03/30/2022

• Partnership status and time to viral suppression and sustained viral suppression among newly diagnosed heterosexual people with HIV.

  (Sohail M, Long DM, Batey DS, Mugavero MJ, Ojesina AI, Levitan EB.) Int J STD AIDS. 2022 Mar;33(4):347-354 PMID: 35085052 PMCID: PMC9364114 01/28/2022

• Genomic alterations associated with mutational signatures, DNA damage repair and chromatin remodeling pathways in cervical carcinoma.

  (Halle MK, Sundaresan A, Zhang J, Pedamallu CS, Srinivasasainagendra V, Blair J, Brooke D, Bertelsen BI, Woie K, Shrestha S, Tiwari H, Wong YF, Krakstad C, Ojesina AI.) NPJ Genom Med. 2021 Oct 07;6(1):82 PMID: 34620846 PMCID: PMC8497615 10/09/2021

• Genomic Characterization and Therapeutic Targeting of HPV Undetected Cervical Carcinomas.

  (Ruiz FJ, Sundaresan A, Zhang J, Pedamallu CS, Halle MK, Srinivasasainagendra V, Zhang J, Muhammad N, Stanley J, Markovina S, Tiwari HK, Grigsby PW, Krakstad C, Schwarz JK, Ojesina AI.) Cancers (Basel). 2021 Sep 10;13(18) PMID: 34572780 PMCID: PMC8467954 09/29/2021

• Immunophenotype-associated gene signature in ductal breast tumors varies by receptor subtype, but the expression of individual signature genes remains consistent.

  (Behring M, Ye Y, Elkholy A, Bajpai P, Agarwal S, Kim HG, Ojesina AI, Wiener HW, Manne U, Shrestha S, Vazquez AI.) Cancer Med. 2021 Aug;10(16):5712-5720 PMID: 34189853 PMCID: PMC8366080 07/01/2021

• Dissection of PIK3CA Aberration for Cervical Adenocarcinoma Outcomes.

  (Chung TKH, Doran G, Cheung TH, Yim SF, Yu MY, Worley MJ Jr, Elias KM, Thorner AR, Pedamallu CS, Ojesina AI, Lau KM, Ducar MD, Wong RRY, Wang VW, Nag A, Wollison BM, Dalgarno A, Lee JHS, Yeung SY, Wong L, Horowitz NS, Davis MR, Leung SA, Mu Y, Mok SC, Chan PKS, Lawrence MS, Crum CP, Chiu RWK, Berkowitz RS, Wong YF.) Cancers (Basel). 2021 Jun 28;13(13) PMID: 34203201 PMCID: PMC8269188 07/03/2021

• A 10-gene prognostic signature points to LIMCH1 and HLA-DQB1 as important players in aggressive cervical cancer disease.

  (Halle MK, Sødal M, Forsse D, Engerud H, Woie K, Lura NG, Wagner-Larsen KS, Trovik J, Bertelsen BI, Haldorsen IS, Ojesina AI, Krakstad C.) Br J Cancer. 2021 May;124(10):1690-1698 PMID: 33723390 PMCID: PMC8110544 03/17/2021

• Inhibiting β-catenin disables nucleolar functions in triple-negative breast cancer.

  (Weeks SE, Kammerud SC, Metge BJ, AlSheikh HA, Schneider DA, Chen D, Wei S, Mobley JA, Ojesina AI, Shevde LA, Samant RS.) Cell Death Dis. 2021 Mar 04;12(3):242 PMID: 33664239 PMCID: PMC7933177 03/06/2021

• Race/ethnicity, sex and insurance disparities in colorectal cancer screening among individuals with and without cardiovascular disease.

  (Sakhuja S, Fowler ME, Ojesina AI.) Prev Med Rep. 2021 Mar;21:101263 PMID: 33391980 PMCID: PMC7773575 01/05/2021

• Author Correction: Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples.

  (Bailey MH, Meyerson WU, Dursi LJ, Wang LB, Dong G, Liang WW, Weerasinghe A, Li S, Li Y, Kelso S, MC3 Working Group, PCAWG novel somatic mutation calling methods working group, Saksena G, Ellrott K, Wendl MC, Wheeler DA, Getz G, Simpson JT, Gerstein MB, Ding L, PCAWG Consortium.) Nat Commun. 2020 Nov 30;11(1):6232 PMID: 33257764 PMCID: PMC7705717 SCOPUS ID: 2-s2.0-85096915769 12/02/2020